AMENDMENT NO. 1 to SECURITIES PURCHASE Follow-Up AGREEMENTSecurities Purchase Follow-Up Agreement • June 10th, 2015 • Ruthigen, Inc. • Pharmaceutical preparations • California
Contract Type FiledJune 10th, 2015 Company Industry JurisdictionThis AMENDMENT NO. 1, dated as of June __, 2015 (the “Amendment”), to the SECURITIES PURCHASE FOLLOW-UP AGREEMENT (the “Follow-Up Agreement”), dated as of March 12, 2015, by and among Oculus Innovative Sciences, Inc., a Delaware corporation, with its principal place of business at 1129 N. McDowell Blvd., Petaluma, CA 94954 (the “Seller”), Michael Brauser and Barry Honig or their respective assignee(s) (collectively, the “Buyer”), Ruthigen, Inc., a Delaware corporation (the “Company”) and Dawson James Securities, Inc. (the “Underwriter”).
SECURITIES PURCHASE Follow-Up AGREEMENTSecurities Purchase Follow-Up Agreement • March 16th, 2015 • Oculus Innovative Sciences, Inc. • Surgical & medical instruments & apparatus • California
Contract Type FiledMarch 16th, 2015 Company Industry JurisdictionThis SECURITIES PURCHASE FOLLOW-UP AGREEMENT (the “Follow-Up Agreement”), dated as of March 13, 2015, by and among Oculus Innovative Sciences, Inc., a Delaware corporation, with its principal place of business at 1129 N. McDowell Blvd., Petaluma, CA 94954 (the “Seller”), Michael Brauser and Barry Honig or their respective assignee(s) (collectively, the “Buyer”), Ruthigen, Inc., a Delaware corporation (the “Company”) and Dawson James Securities, Inc. (the “Underwriter”).
SECURITIES PURCHASE Follow-Up AGREEMENTSecurities Purchase Follow-Up Agreement • March 13th, 2015 • Ruthigen, Inc. • Pharmaceutical preparations • California
Contract Type FiledMarch 13th, 2015 Company Industry JurisdictionThis SECURITIES PURCHASE FOLLOW-UP AGREEMENT (the “Follow-Up Agreement”), dated as of March 12, 2015, by and among Oculus Innovative Sciences, Inc., a Delaware corporation, with its principal place of business at 1129 N. McDowell Blvd., Petaluma, CA 94954 (the “Seller”), Michael Brauser and Barry Honig or their respective assignee(s) (collectively, the “Buyer”), Ruthigen, Inc., a Delaware corporation (the “Company”) and Dawson James Securities, Inc. (the “Underwriter”).